HOME >> BIOLOGY >> NEWS
Modified herpes virus keeps arteries 'free-flowing' following procedures

A genetically engineered herpes simplex virus, primarily known for causing cold sores, may help keep arteries free-flowing in the weeks following angioplasty or stent placement for patients, according to research published early in the online edition of PNAS (Proceedings of the National Academy of Sciences of the United States of America).

Christopher Skelly, MD, assistant professor of vascular surgery at the University of Chicago Medical Center, and the studys lead author says, One of the drawbacks of balloon angioplasty to open blocked arteries and the use of stents to keep them open is that arteries sometimes experience aggravation from the procedure. The balloon angioplasty, in addition to opening the artery can lead to smooth muscle cell proliferation, similar to formation of scar tissue, known as neointimal hyperplasia. This scar tissue can restrict blood flow not long after the procedures, leading to a recurrence of symptoms. A significant number of these cases end up requiring further intervention to address this complication.

Researchers at the University of Chicago noted that in recent years, genetically engineered herpes simplex virus studied for its efficacy against malignant tumors of the central nervous system and the liver was blocking certain types of cell death and proliferation of surviving cells. They wanted to test this effect in arteries following angioplasty therapy.

The researchers studied a rabbit model that replicates the restenosis or renarrowing after angioplasty. Rabbits that underwent angioplasty alone experienced significant narrowing of the artery. Rabbits exposed to the herpes simplex virus during angioplasty had minimal changes in the arteries. The smooth muscle cell proliferation which causes the restenosis was very low in the group treated with herpes and remained high in the untreated group.

One undesirable, yet expected outcome of angioplasty and stent placement is the disruption o
'"/>

Contact: Scot Roskelley
scot.roskelley@uchospitals.edu
773-795-0892
University of Chicago Medical Center
10-Jul-2007


Page: 1 2

Related biology news :

1. Modified mushrooms may yield human drugs
2. Insulator helps silence genes in dormant herpes virus
3. Anti-herpes treatment reduces HIV levels in women infected with both viruses
4. Research holds promise for herpes vaccine
5. Achilles heel of the herpes virus possibly found
6. Live vaccines more effective against horse herpes virus
7. Licorice licks herpes virus infection
8. Topical treatment shown to inhibit HIV and herpes simplex virus infection
9. Features of replication suggest viruses have common themes, vulnerabilities
10. Marijuana component opens the door for virus that causes Kaposis sarcoma
11. Discovery in plant virus may help prevent HIV and similar viruses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2020)... ... May 26, 2020 , ... ... today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer ... and TCR-based therapeutics, has implemented Genedata Biologics ® within their R&D ...
(Date:5/21/2020)... ... ... Law Enforcement has always been a highly stressful career – serving to ... men and women put them constantly in harm’s way both from the criminal element ... had to face very high daily stress. Now, COVID-19 introduces another even greater degree ...
(Date:5/14/2020)... , ... May 14, 2020 , ... ... board for medical sales representatives, found the 2019 average medical sales rep total ... risk being shadowed by uncertainties amid the COVID-19 global crisis. , The MedReps ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... April 06, 2020 , ... Red ... life sciences industry, has announced the release of at-home virtual learning resources for ... is the health and safety of our employees as we continue to implement ...
(Date:4/1/2020)... , ... March 30, 2020 , ... ... telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to bring telehealth ... by creating in-home tests for COVID-19. Company officials are currently?awaiting an Emergency Use ...
(Date:4/1/2020)... SALT LAKE CITY, and LA JOLLA, Calif. (PRWEB) , ... March ... ... and characterization tools, and La Jolla Institute for Immunology (LJI), announced today that they ... few days allowing CoVIC to move therapeutic candidates to the clinic as early as ...
(Date:3/27/2020)... ... March 25, 2020 , ... ... located centrally in the midwest for high-quality, quick-turn, board-certified reporting. In an ... motivated, independent, professional team that is focused on incredible quality, turnaround time ...
Breaking Biology Technology:
Cached News: